EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Resurgence of Chikungunya virus: rising global threat and challenges in its mitigation

Priyadarshi Soumyaranjan Sahu, Ritesh Pattnaik, Mohammed Alissa, Ghadah S Abusalim, Alaa S Alhegaili, Ghfren S Aloraini, Abdulkarim S Binshaya, Ghada M Alnafesah, Subrat Kumar

Frontiers in Pharmacology · 22.04.2026 · 17

DOI: 10.3389/fphar.2026.1757035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.04.2026. Verfasst von Priyadarshi Soumyaranjan Sahu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pre-clinical Medicine, Medical University of the Americas, Nevis, West Indies. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) is an arthropod-borne viral disease which spreads to humans by mosquito bites, inducing musculoskeletal pain and fever. CHIKV was endemic to the Indian Ocean region till 2004 that affected millions. It has been expanding its existence to non-endemic regions in Europe, the Middle East and the Pacific regions since 2004. Current fast CHIKV transmission scenario highlights the necessity of innovating control methods and devising novel diagnostic techniques. Conventional vector control measures lack efficacy as CHIKV vector evolves. Also, the existing assays used to detect CHIKV vary on sensitivity and specificity. This leads to mis-reporting or under-reporting of CHIKV cases especially in the endemic regions. This review discusses the CHIKV pathogenesis, an overview of various existing detection and the mitigation measures. Later, the challenges and limitations posed by these and how they can be subjugated by employing various simple and sustainable measures are emphasised. This review also suggests strategies to deploy novel systems in resource-limited settings to effectively address the infection and transmission of CHIKV disease.

Schlagwörter

Stichwörter der Autor:innen

chikungunya virusemerging diseaseneglected tropical diseaseoutbreakvaccine developmentvector

Autor:innen und Institutionen

  • Faculty of Pre-clinical Medicine, Medical University of the Americas, Nevis, West Indies.
  • School of Biotechnology, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India.
  • Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.

Zitieren

APA

Sahu, P. S., Pattnaik, R., Alissa, M., Abusalim, G. S., Alhegaili, A. S., Aloraini, G. S., Binshaya, A. S., Alnafesah, G. M., & Kumar, S. (2026). Resurgence of Chikungunya virus: rising global threat and challenges in its mitigation. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1757035

Vancouver

Sahu PS, Pattnaik R, Alissa M, Abusalim GS, Alhegaili AS, Aloraini GS, et al. Resurgence of Chikungunya virus: rising global threat and challenges in its mitigation. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1757035

BibTeX
@article{Sahu2026,
  author = {Sahu, Priyadarshi Soumyaranjan and Pattnaik, Ritesh and Alissa, Mohammed and Abusalim, Ghadah S and Alhegaili, Alaa S and Aloraini, Ghfren S and Binshaya, Abdulkarim S and Alnafesah, Ghada M and Kumar, Subrat},
  title = {Resurgence of Chikungunya virus: rising global threat and challenges in its mitigation},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1757035}
}
Kostenlos starten →